Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manja Meggendorfer

Showing results (51-60 of 125) with videos related to

Pageof 13
Sort By:
Experimental Hematology|February 5, 2022
Acute myeloid leukemia exhibiting clonal instability during treatment: Implications for measurable residual disease assessmentsAnita T Simonsen, Manja Meggendorfer, Marcus H Hansen, et al.
Blood|August 25, 2012
SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML)Manja Meggendorfer, Andreas Roller, Torsten Haferlach, et al.
Haematologica|July 16, 2026
Incidence, molecular and clinical characteristics of donor-derived hematologic malignancies after allogeneic stem cell transplantation for myeloid malignanciesTetiana Perekhrestenko, Anita Badbaran, Evgeny Klyuchnikov, et al.
Blood|April 21, 2017
Response and progression on midostaurin in advanced systemic mastocytosis: <i>KIT</i> D816V and other molecular markersMohamad Jawhar, Juliana Schwaab, Nicole Naumann, et al.
Blood Advances|October 24, 2023
The clinical and genomic landscape of patients with DDX41 variants identified during diagnostic sequencingAnna Maierhofer, Nikita Mehta, Ryan A Chisholm, et al.
Seminars in Cancer Biology|June 13, 2021
Analytical demands to use whole-genome sequencing in precision oncologyManja Meggendorfer, Vaidehi Jobanputra, Kazimierz O Wrzeszczynski, et al.
Haematologica|March 4, 2017
The clinical and molecular diversity of mast cell leukemia with or without associated hematologic neoplasmMohamad Jawhar, Juliana Schwaab, Manja Meggendorfer, et al.
Stroke|February 15, 2023
Prevalence and Therapeutic Implications of Clonal Hematopoiesis of Indeterminate Potential in Young Patients With StrokeErnst Mayerhofer, Christoph Strecker, Heiko Becker, et al.
Blood Advances|August 27, 2021
Splicing factor gene mutations in acute myeloid leukemia offer additive value if incorporated in current risk classificationInge van der Werf, Anna Wojtuszkiewicz, Manja Meggendorfer, et al.
Blood|June 24, 2020
Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasmsLaura Palomo, Manja Meggendorfer, Stephan Hutter, et al.
Pageof 13

Showing results (51-60 of 125) with videos related to

Sort By:
Pageof 13
Experimental Hematology|February 5, 2022
Acute myeloid leukemia exhibiting clonal instability during treatment: Implications for measurable residual disease assessmentsAnita T Simonsen, Manja Meggendorfer, Marcus H Hansen, et al.
Blood|August 25, 2012
SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML)Manja Meggendorfer, Andreas Roller, Torsten Haferlach, et al.
Haematologica|July 16, 2026
Incidence, molecular and clinical characteristics of donor-derived hematologic malignancies after allogeneic stem cell transplantation for myeloid malignanciesTetiana Perekhrestenko, Anita Badbaran, Evgeny Klyuchnikov, et al.
Blood|April 21, 2017
Response and progression on midostaurin in advanced systemic mastocytosis: <i>KIT</i> D816V and other molecular markersMohamad Jawhar, Juliana Schwaab, Nicole Naumann, et al.
Blood Advances|October 24, 2023
The clinical and genomic landscape of patients with DDX41 variants identified during diagnostic sequencingAnna Maierhofer, Nikita Mehta, Ryan A Chisholm, et al.
Seminars in Cancer Biology|June 13, 2021
Analytical demands to use whole-genome sequencing in precision oncologyManja Meggendorfer, Vaidehi Jobanputra, Kazimierz O Wrzeszczynski, et al.
Haematologica|March 4, 2017
The clinical and molecular diversity of mast cell leukemia with or without associated hematologic neoplasmMohamad Jawhar, Juliana Schwaab, Manja Meggendorfer, et al.
Stroke|February 15, 2023
Prevalence and Therapeutic Implications of Clonal Hematopoiesis of Indeterminate Potential in Young Patients With StrokeErnst Mayerhofer, Christoph Strecker, Heiko Becker, et al.
Blood Advances|August 27, 2021
Splicing factor gene mutations in acute myeloid leukemia offer additive value if incorporated in current risk classificationInge van der Werf, Anna Wojtuszkiewicz, Manja Meggendorfer, et al.
Blood|June 24, 2020
Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasmsLaura Palomo, Manja Meggendorfer, Stephan Hutter, et al.
Pageof 13